Abstract:Cancer metastasis is associated with epithelial-mesenchymal transition (EMT), and NMII is linked to EMT. Calcium sensitization through ROCK activates myosin II, contributing to metastasis. NMII undergoes phosphorylation at Thr18/Ser19, affecting its function and involvement in processes like exocytosis, apoptosis, and transcellular intravasations. Inhibition of myosin II ATPase activity blocks cytokinesis, highlighting its role in cell cycle regulation. NMII has distinct binding motifs and sites for regulation, including Thr18/Ser19 via kinases/phosphatases, Ser1/Ser2/Thr9 via phosphokinase C, and involvement in cytokinesis via contractile ring formation. These characteristics make NMII a potential therapeutic target. NMII-C is found to be less expressive in glioma (40% low expression, 60% high expression), not showing prognostic value. However, in stomach cancer (35–65% expression) and renal cancer (40–60% expression), NMII-C appears to have prognostic significance. NMII-C's prognostic value has not been reported in various other cancers, including thyroid, lung, liver, colorectal, urothelial, endometrial, head and neck, melanoma, prostate, testicular, pancreatic, breast, cervical, and ovarian cancers, highlighting a need for further research in these areas. Some pharmacological agents such as Blebbistatin, DT-13, Statins, and Y27632 have shown promising potential against NMII-C in cancer therapy, with positive results in pre-clinical studies and ongoing clinical trials. Understanding the specific functions and regulation of NMII isoforms, particularly NMII-C, may provide valuable insights into the development of targeted cancer therapies. Additionally, the study suggests that NMII-C may have prognostic importance in specific cancer stages, offering a foundation for further exploration of NMII-C's mechanisms of action for future medical interventions.

Nonmuscle Myosin II Regulation Directs Its Multiple Roles in Cell Migration and Division

Non-muscle Myosin II Takes Centre Stage in Cell Adhesion and Migration.

Progress in research on non-muscle myosin II

Non-Muscle Myosin 2A (NM2A): Structure, Regulation and Function

NMII Forms a Contractile Transcellular Sarcomeric Network to Regulate Apical Cell Junctions and Tissue Geometry

Distinct and Redundant Roles of the Non-Muscle Myosin II Isoforms and Functional Domains.

Mechanosensitive accumulation of non-muscle myosin IIB during mitosis requires its translocation activity

Progress in research on non-muscle myosin Ⅱ

Structure, regulation, and mechanisms of nonmuscle myosin-2

Nonmuscle myosin IIA and IIB differentially contribute to intrinsic and directed migration of human embryonic lung fibroblasts

Nonmuscle Myosin II Exerts Tension but Does Not Translocate Actin in Vertebrate Cytokinesis

Actomyosin forces in cell migration: Moving beyond cell body retraction

The Enzymatic Motor Activity Of Nonmuscle Myosin Ii-B Is Not Critical For Cardiac Myocyte Cytokinesis

Non-muscle myosin II isoforms orchestrate substrate stiffness sensing to promote cancer cell contractility and migration

Nonmuscle myosin 2 filaments are processive in cells

Myosin II isoforms play distinct roles in adherens junction biogenesis

Myosin II directly binds and inhibits Dbl family guanine nucleotide exchange factors: a possible link to Rho family GTPases

Nonmuscle Myosin II Isoform and Domain Specificity During Early Mouse Development

Drosophila non-muscle myosin II motor activity determines the rate of tissue folding

Non-Muscle Myosin IIC as a Prognostic and Therapeutic Target in Cancer

A Genetically Encoded Biosensor Strategy for Quantifying Non-muscle Myosin II Phosphorylation Dynamics in Living Cells and Organisms.